Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Disruption of polycomb repressor complex-mediated gene silencing reactivates HIV-1 provirus in latently infected cells.

Yoon CH, Jang DH, Kim KC, Park SY, Kim HY, Kim SS, Chi SG, Choi BS.

Intervirology. 2014;57(2):116-20. doi: 10.1159/000360224.

PMID:
24642637
2.

Gene silencing in HIV-1 latency by polycomb repressive group.

Kim HG, Kim KC, Roh TY, Park J, Jung KM, Lee JS, Choi SY, Kim SS, Choi BS.

Virol J. 2011 Apr 18;8:179. doi: 10.1186/1743-422X-8-179.

3.

Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.

Trejbalová K, Kovářová D, Blažková J, Machala L, Jilich D, Weber J, Kučerová D, Vencálek O, Hirsch I, Hejnar J.

Clin Epigenetics. 2016 Feb 19;8:19. doi: 10.1186/s13148-016-0185-6.

4.

Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.

Friedman J, Cho WK, Chu CK, Keedy KS, Archin NM, Margolis DM, Karn J.

J Virol. 2011 Sep;85(17):9078-89. doi: 10.1128/JVI.00836-11.

5.
6.

Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.

Hori T, Barnor J, Huu TN, Morinaga O, Hamano A, Ndzinu J, Frimpong A, Minta-Asare K, Amoa-Bosompem M, Brandful J, Odoom J, Bonney J, Tuffour I, Owusu BA, Ofosuhene M, Atchoglo P, Sakyiamah M, Adegle R, Appiah-Opong R, Ampofo W, Koram K, Nyarko A, Okine L, Edoh D, Appiah A, Uto T, Yoshinaka Y, Uota S, Shoyama Y, Yamaoka S.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):288-93. doi: 10.1016/j.bbrc.2015.02.102. Erratum in: Biochem Biophys Res Commun. 2015 Jun 12;461(4):702.

PMID:
25727021
7.

HIV-1 latency in actively dividing human T cell lines.

Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B.

Retrovirology. 2008 Apr 25;5:37. doi: 10.1186/1742-4690-5-37.

8.

CpG methylation controls reactivation of HIV from latency.

Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, Verdin E, Olive D, Van Lint C, Hejnar J, Hirsch I.

PLoS Pathog. 2009 Aug;5(8):e1000554. doi: 10.1371/journal.ppat.1000554.

9.

Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Jadlowsky JK, Wong JY, Graham AC, Dobrowolski C, Devor RL, Adams MD, Fujinaga K, Karn J.

Mol Cell Biol. 2014 Jun;34(11):1911-28. doi: 10.1128/MCB.01013-13.

10.

H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.

Tripathy MK, McManamy ME, Burch BD, Archin NM, Margolis DM.

J Virol. 2015 Aug;89(16):8392-405. doi: 10.1128/JVI.00572-15.

11.

HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.

Lin S, Zhang Y, Ying H, Zhu H.

Curr HIV Res. 2011 Jun;9(4):202-8. doi: 10.2174/157016211796320333.

PMID:
21631428
12.

High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Iglesias-Ussel M, Vandergeeten C, Marchionni L, Chomont N, Romerio F.

J Virol. 2013 Aug;87(16):9148-58. doi: 10.1128/JVI.01297-13.

13.

Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.

Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, Sluis-Cremer N.

J Biol Chem. 2011 Jun 24;286(25):22211-8. doi: 10.1074/jbc.M110.180224.

15.

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR, Pomerantz RJ.

Blood. 2001 Nov 15;98(10):3006-15.

17.

Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment.

van der Sluis RM, van Capel TM, Speijer D, Sanders RW, Berkhout B, de Jong EC, Jeeninga RE, van Montfort T.

AIDS. 2015 Jun 1;29(9):1003-14. doi: 10.1097/QAD.0000000000000637.

PMID:
25768834
18.

Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.

Munier S, Delcroix-Genête D, Carthagéna L, Gumez A, Hazan U.

Retrovirology. 2005 Nov 23;2:73.

19.

TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.

Thibault S, Imbeault M, Tardif MR, Tremblay MJ.

Virology. 2009 Jun 20;389(1-2):20-5. doi: 10.1016/j.virol.2009.04.019.

20.

Supplemental Content

Support Center